Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Covid-19 in kidney transp… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Covid-19 in kidney transplant recipients: a systematic review of the case series available three months into the pandemic.

Artikel i vetenskaplig tidskrift
Författare Mihai Oltean
John Mackay Søfteland
Jasmine Bagge
Jan Ekelund
Marie Felldin
Andreas Schult
Jesper Magnusson
Vanda Friman
Kristjan Karason
Publicerad i Infectious diseases (London, England)
Sidor 1-8
ISSN 2374-4243
Publiceringsår 2020
Publicerad vid Institutionen för biomedicin
Institutionen för biomedicin, avdelningen för infektionssjukdomar
Sidor 1-8
Språk en
Länkar dx.doi.org/10.1080/23744235.2020.17...
www.ncbi.nlm.nih.gov/entrez/query.f...
Ämneskategorier Infektionsmedicin, Transplantationskirurgi, Klinisk medicin

Sammanfattning

Coronavirus disease 2019 (COVID-19) ranges from a mild illness to acute respiratory distress syndrome (ARDS), multiorgan dysfunction, and death. Transplant recipients are vulnerable due to comorbidities and immunosuppressants that render them susceptible to infections. The information on COVID-19 in kidney transplant recipients remains limited to small case series.A systematic literature search was conducted, and 12 case series totalling 204 kidney transplant recipients with COVID-19 were identified. Data were extracted, pooled and analysed.Most patients (74%) were men. The most frequent symptoms were fever (76%), cough (64%) and dyspnoea (43%). At admission, over 70% of the patients had abnormal radiological findings. Leukocyte counts were in the lower normal range. C-reactive protein, ferritin, and D-dimer were consistently increased. Treatments included lowering immunosuppression, hydroxychloroquine, antivirals, tocilizumab and intravenous immunoglobulins. Thirty-one percent of the patients were admitted to intensive care units (ICUs), and 16% required intubation. The overall mortality was 21.2%. Patients who died were significantly older than those who survived (61 ± 12 vs. 51 ± 15, p < .01). Logistic regression revealed that the odds for death increased by 4.3% for each additional year of age (odds ratio [OR] 1.043, 95% confidence interval [CI] 1.005-1.083, p value = .0265).No substantial conclusions could be drawn on the efficacy of any particular treatment. More rigorous patient stratification is needed when analysing and reporting data to facilitate future meta-analyses.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?